409 related articles for article (PubMed ID: 20924332)
1. Catheter-based renal sympathectomy.
Id D; Bertog SC; Wunderlich N; Sievert H
J Cardiovasc Surg (Torino); 2010 Oct; 51(5):721-39. PubMed ID: 20924332
[TBL] [Abstract][Full Text] [Related]
2. Expanding the indication spectrum: renal denervation in diabetes.
Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
[TBL] [Abstract][Full Text] [Related]
3. What we need to know about renal nerve ablation for treatment of hypertension and other states of sympathetic overactivity.
Schlaich MP
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1267-F1270. PubMed ID: 27630063
[TBL] [Abstract][Full Text] [Related]
4. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
Kjeldsen SE; Os I; Mahfoud F
EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
[No Abstract] [Full Text] [Related]
5. Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited.
Tam GM; Yan BP; Shetty SV; Lam YY
Int J Cardiol; 2013 Apr; 164(3):277-81. PubMed ID: 22336259
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology I: the kidney and the sympathetic nervous system.
de Jager RL; Blankestijn PJ
EuroIntervention; 2013 May; 9 Suppl R():R42-7. PubMed ID: 23732154
[TBL] [Abstract][Full Text] [Related]
7. The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation.
Grassi G; Seravalle G; Brambilla G; Mancia G
Can J Cardiol; 2012 May; 28(3):311-7. PubMed ID: 22244774
[TBL] [Abstract][Full Text] [Related]
8. Renal denervation for resistant hypertension and beyond.
Laffin LJ; Bakris GL
Adv Chronic Kidney Dis; 2015 Mar; 22(2):133-9. PubMed ID: 25704350
[TBL] [Abstract][Full Text] [Related]
9. Renal denervation: a plea for wisdom.
Lantelme P; Courand PY; Pathak A
Arch Cardiovasc Dis; 2013 Mar; 106(3):121-3. PubMed ID: 23582673
[No Abstract] [Full Text] [Related]
10. Renal denervation for hypertension.
Bertog SC; Sobotka PA; Sievert H
JACC Cardiovasc Interv; 2012 Mar; 5(3):249-58. PubMed ID: 22440489
[TBL] [Abstract][Full Text] [Related]
11. Recent Developments and Controversies in the Treatment of Resistant Hypertension.
Kühl C; Frey N; Frank D
Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):178-86. PubMed ID: 27008634
[TBL] [Abstract][Full Text] [Related]
12. The pathophysiological basis of renal nerve ablation for the treatment of hypertension.
Ziakas A; Gossios T; Doumas M; Karali K; Megarisiotou A; Stiliadis I
Curr Vasc Pharmacol; 2014 Jan; 12(1):23-9. PubMed ID: 23905601
[TBL] [Abstract][Full Text] [Related]
13. Follow-up, study design and outcome parameters.
Volpe M; Battistoni A; Tocci G
EuroIntervention; 2013 May; 9 Suppl R():R96-100. PubMed ID: 23732163
[TBL] [Abstract][Full Text] [Related]
14. Renal denervation in the treatment of resistant arterial hypertension.
Lambert T; Schützenberger W; Steinwender C
Wien Med Wochenschr; 2014 Dec; 164(23-24):515-8. PubMed ID: 25394989
[TBL] [Abstract][Full Text] [Related]
15. Renal denervation and heart failure.
Böhm M; Ewen S; Kindermann I; Linz D; Ukena C; Mahfoud F
Eur J Heart Fail; 2014 Jun; 16(6):608-13. PubMed ID: 24644008
[TBL] [Abstract][Full Text] [Related]
16. Current technologies: an introduction.
Daemen J
EuroIntervention; 2013 May; 9 Suppl R():R75-82. PubMed ID: 23732160
[No Abstract] [Full Text] [Related]
17. Sympathetic nervous system: role in hypertension and in chronic kidney disease.
Grassi G; Bertoli S; Seravalle G
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):46-51. PubMed ID: 22080859
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
Hering D; Esler MD; Schlaich MP
EuroIntervention; 2013 May; 9 Suppl R():R127-35. PubMed ID: 23732145
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
Schlaich MP; Bart B; Hering D; Walton A; Marusic P; Mahfoud F; Böhm M; Lambert EA; Krum H; Sobotka PA; Schmieder RE; Ika-Sari C; Eikelis N; Straznicky N; Lambert GW; Esler MD
Int J Cardiol; 2013 Oct; 168(3):2214-20. PubMed ID: 23453868
[TBL] [Abstract][Full Text] [Related]
20. Potential new indications and future studies.
Sudano I; Noll G; Luscher TF
EuroIntervention; 2013 May; 9 Suppl R():R155-60. PubMed ID: 23732149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
